BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20104121)

  • 1. Hepatitis C and the risk of kidney disease and mortality in veterans with HIV.
    Fischer MJ; Wyatt CM; Gordon K; Gibert CL; Brown ST; Rimland D; Rodriguez-Barradas MC; Justice AC; Parikh CR;
    J Acquir Immune Defic Syndr; 2010 Feb; 53(2):222-6. PubMed ID: 20104121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
    Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
    Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
    Lucas GM; Jing Y; Sulkowski M; Abraham AG; Estrella MM; Atta MG; Fine DM; Klein MB; Silverberg MJ; Gill MJ; Moore RD; Gebo KA; Sterling TR; Butt AA;
    J Infect Dis; 2013 Oct; 208(8):1240-9. PubMed ID: 23904290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
    Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
    AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
    Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy.
    Lo Re V; Kostman JR; Gross R; Reddy KR; Mounzer K; Zemel BS; Rennert H; Stieritz DD; Putt M; Frank I; Strom BL
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):344-50. PubMed ID: 17179767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
    Tsui J; Vittinghoff E; Anastos K; Augenbraun M; Young M; Nowicki M; Cohen MH; Peters MG; Golub ET; Szczech L
    Am J Kidney Dis; 2009 Jul; 54(1):43-50. PubMed ID: 19394735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C.
    Freiberg MS; Chang CC; Skanderson M; McGinnis K; Kuller LH; Kraemer KL; Rimland D; Goetz MB; Butt AA; Rodriguez Barradas MC; Gibert C; Leaf D; Brown ST; Samet J; Kazis L; Bryant K; Justice AC;
    Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):425-32. PubMed ID: 21712519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
    Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
    Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study.
    Clement ME; Park LP; Navar AM; Okeke NL; Pencina MJ; Douglas PS; Naggie S
    Clin Infect Dis; 2016 Aug; 63(3):407-13. PubMed ID: 27143663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV infection and the incidence of CKD.
    Butt AA; Wang X; Fried LF
    Am J Kidney Dis; 2011 Mar; 57(3):396-402. PubMed ID: 21185632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
    Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users.
    Sanvisens A; Fuster D; Serra I; Tor J; Tural C; Rey-Joly C; Muga R
    Curr HIV Res; 2011 Jun; 9(4):256-62. PubMed ID: 21675942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
    Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
    BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.
    Chen TY; Ding EL; Seage Iii GR; Kim AY
    Clin Infect Dis; 2009 Nov; 49(10):1605-15. PubMed ID: 19842982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    J Viral Hepat; 2006 Dec; 13(12):799-810. PubMed ID: 17109679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women.
    Tien PC; Bacchetti P; Gripshover B; Overton ET; Rimland D; Kotler D;
    J Acquir Immune Defic Syndr; 2007 May; 45(1):60-5. PubMed ID: 17356466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Rogal SS; Yan P; Rimland D; Lo Re V; Al-Rowais H; Fried L; Butt AA;
    Dig Dis Sci; 2016 Mar; 61(3):930-6. PubMed ID: 26526451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in siblings of patients coinfected with HIV and hepatitis C virus.
    Hansen AB; Gerstoft J; Kronborg G; Pedersen C; Sorensen HT; Obel N
    J Infect Dis; 2007 Jan; 195(2):230-5. PubMed ID: 17191168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.